Welcome to our dedicated page for Goldman Sachs Group SEC filings (Ticker: GS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Goldman Sachs Group, Inc. files regulatory documents that cover operating results, material events, capital structure and corporate governance. Its 8-K filings document earnings releases, Regulation FD disclosures, debt and subordinated debt issuances under shelf registration statements, and changes involving directors or executive officers.
The filing record also identifies Goldman Sachs’ NYSE-listed common stock, preferred depositary shares, capital securities and medium-term notes issued by GS Finance Corp. Proxy materials disclose annual meeting matters, board governance, executive compensation and shareholder voting items, while registration-related exhibits document securities offerings and related terms.
A holder of The Goldman Sachs Group, Inc. common stock has filed to sell 113 shares on the NYSE through Goldman Sachs & Co. LLC, with an aggregate market value of $104,948.75 and an approximate sale date of February 9, 2026.
The shares were acquired on the same date as employee compensation awards from The Goldman Sachs Group, Inc. Over the prior three months, related sellers Virgo 10 Trust, Leo 19 Trust, and Alex S. Golten sold 546, 546, and 1,087 shares, respectively, for total gross proceeds above $2.0 million.
GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., is offering Buffered Digital S&P 500® Index-Linked Notes due 2033 under its Medium-Term Notes, Series F program. The notes’ payoff depends on S&P 500 performance between the trade date and determination date.
For each $1,000 face amount, if the final S&P 500 level is at or above 90% of its initial level, investors receive the maximum settlement amount of $1,665. If the final level is below 90%, principal is reduced 1% for each 1% drop below that buffer, so investors can lose a substantial portion of principal.
The notes pay no interest, have capped upside, and offer no rights in S&P 500 constituent stocks. They are subject to the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc., potential secondary-market discounts, and uncertain U.S. federal tax treatment.
The Goldman Sachs Group, Inc. is issuing $12,000,000 of callable fixed rate notes due February 10, 2031, paying interest at 4.65% per annum. Interest is paid annually on February 10, beginning February 10, 2027.
The notes may be redeemed at Goldman Sachs’ option, in whole but not in part, on specified quarterly redemption dates on or after February 10, 2027 at 100% of principal plus accrued interest. The initial price to the public is 100% of principal, with an underwriting discount of 0.502% and estimated proceeds to Goldman Sachs of $11,939,760 before expenses.
4D Molecular Therapeutics reported that affiliates of The Goldman Sachs Group, Inc., including Goldman Sachs & Co. LLC, beneficially owned 4,286,077.48 shares of its common stock as of 12/31/2025. This represents 7.5% of the company’s outstanding common shares.
The Goldman Sachs entities report shared voting power over 4,286,060.48 shares and shared dispositive power over 4,286,077.48 shares, with no sole voting or dispositive power. They state the position is held in the ordinary course of business and not for the purpose of changing or influencing control of 4D Molecular Therapeutics.
4D Molecular Therapeutics reported that affiliates of The Goldman Sachs Group, Inc., including Goldman Sachs & Co. LLC, beneficially owned 4,286,077.48 shares of its common stock as of 12/31/2025. This represents 7.5% of the company’s outstanding common shares.
The Goldman Sachs entities report shared voting power over 4,286,060.48 shares and shared dispositive power over 4,286,077.48 shares, with no sole voting or dispositive power. They state the position is held in the ordinary course of business and not for the purpose of changing or influencing control of 4D Molecular Therapeutics.
GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., is issuing stock-linked notes tied to Kratos Defense & Security Solutions, Inc. common stock. The notes pay no interest and mature on February 8, 2029, unless automatically called earlier.
The notes are automatically redeemed on February 10, 2027 for $1,530 per $1,000 if Kratos’ stock on the call observation date is at or above the initial price of $85.25. If not called, maturity payments depend on the final stock price: investors get 1.5x the stock gain if it is above the initial price, full principal back if the stock is down by up to 50%, and a proportional loss if it falls by more than 50%, which can mean losing the entire investment.
The aggregate face amount is $5.47 million, with an estimated value of about $968 per $1,000 at pricing. Returns depend on Kratos’ share performance and the credit of GS Finance Corp. and The Goldman Sachs Group, Inc., and the notes are expected to have limited liquidity and significant market and structural risks.
GS Finance Corp. offers autocallable, index-linked notes due February 24, 2033 guaranteed by The Goldman Sachs Group, Inc., linked to the Goldman Sachs Momentum Builder® Focus ER Index. Each $1,000 face amount pays an annual automatic call if the index meets rising call levels; otherwise cash at maturity depends on the index return with a 100% upside participation rate.
The pricing supplement states the estimated value on the trade date is $850 to $890 per $1,000 face amount and that the original issue price exceeds that estimate. Key dates include a trade date February 19, 2026, original issue date February 24, 2026 and determination date February 16, 2033. Call observation/payment schedule and call premiums are specified for annual windows from February 19, 2027 through February 26, 2032.
GS Finance Corp., guaranteed by The Goldman Sachs Group, Inc., is offering Buffered Digital S&P 500® Index-Linked Notes due March 2, 2029. The notes are linked to the S&P 500 Index and pay no interest.
At maturity, if the final index level is at or above the initial level, holders receive a maximum upside settlement amount of $1,180 per $1,000 face amount. If the index is below the initial level but not lower than 80% of it, investors earn 360% of the absolute index loss, up to that $1,180 cap. If the index falls more than 20% below the initial level, principal is exposed 1-for-1 below the 80% buffer and investors can lose a substantial portion of their investment.
The issue price exceeds the model-based estimated value of the notes, and secondary market prices may be lower due to dealer spreads, commissions and changing market conditions. Investors face the credit risk of GS Finance Corp. and its parent guarantor, have no rights in S&P 500 stocks, and are subject to uncertain U.S. tax treatment, including potential FATCA and section 871(m) considerations.
GS Finance Corp. is offering EURO STOXX 50® Index-linked notes due 2028, guaranteed by The Goldman Sachs Group, Inc. The notes pay no interest and the cash you receive at maturity depends on index performance and whether a barrier event occurs.
If the index ever closes above 135% of its initial level during the measurement period, a barrier event occurs and you receive at least $1,175 per $1,000 note at maturity, a minimum 17.5% gain, regardless of the final index level. If no barrier event occurs, upside is tied to index gains up to a 35% maximum, while downside is limited by a minimum settlement amount of $950 per $1,000 note. The estimated value at pricing is expected between $900 and $930 per $1,000, below the 100% issue price, and the notes are subject to the credit risk of both GS Finance Corp. and The Goldman Sachs Group, Inc.
GS Finance Corp. (guaranteed by The Goldman Sachs Group, Inc.) offers auto-callable principal-at-risk notes linked to Bloom Energy Corporation Class A common stock due February 15, 2028. The notes pay $1,400 per $1,000 if the underlying closes at or above the initial share price on the call observation date (expected February 17, 2027), otherwise payoff at maturity depends on the final share price and a leverage factor set at least 340.00%. The downside threshold is 50.00% of the initial share price; if final price is below that threshold investors bear 1:1 downside risk. The cover shows an estimated value range of $860 to $920 per security and an underwriting discount of 2.50%.
The Goldman Sachs Group, Inc. is offering $50,000,000 of fixed and floating rate notes due March 9, 2027. The notes are issued at 100% of principal, with an underwriting discount of 0.035% and net proceeds of 99.965% of principal to Goldman Sachs.
From February 9, 2026 to May 9, 2026, the notes pay a fixed annual rate of 4.125%, with interest paid monthly. From May 9, 2026 to March 9, 2027, interest is based on compounded SOFR + 0.15%, with a minimum rate of 0.50% per year, also paid monthly. The notes are unsecured, not FDIC insured, not redeemable before maturity, and will not be listed on any exchange.